A study revealed that PDGF-A is increased in the dermal interstitial blister fluid of SSc patients (150) and blockade of PDGF receptors by Crenolanib is effective in reducing skin fibrosis in preclinical models of SSc (151). Here, PDGFA is linked to systemic sclerosis.